SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-21-007329
Filing Date
2021-03-26
Accepted
2021-03-26 17:01:21
Documents
98
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K navb20201231_10k.htm 10-K 2145568
2 EXHIBIT 21.1 ex_235636.htm EX-21.1 6177
3 EXHIBIT 23.1 ex_235637.htm EX-23.1 3546
4 EXHIBIT 24.1 ex_235638.htm EX-24.1 13788
5 EXHIBIT 31.1 ex_235639.htm EX-31.1 8489
6 EXHIBIT 32.1 ex_235640.htm EX-32.1 4310
13 ma01.jpg GRAPHIC 4659
14 marcumlogo02.jpg GRAPHIC 12113
15 n01.jpg GRAPHIC 30522
  Complete submission text file 0001437749-21-007329.txt   10215852

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT navb-20201231.xml EX-101.INS 1781156
8 XBRL TAXONOMY EXTENSION SCHEMA navb-20201231.xsd EX-101.SCH 98723
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE navb-20201231_cal.xml EX-101.CAL 51692
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE navb-20201231_def.xml EX-101.DEF 817545
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE navb-20201231_lab.xml EX-101.LAB 588879
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE navb-20201231_pre.xml EX-101.PRE 836962
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35076 | Film No.: 21778303
SIC: 2835 In Vitro & In Vivo Diagnostic Substances